Skip to main content
European Commission logo print header

ACCURATE EASY-TO-USE AND NON-INVASIVE DEVICE FOR EARLY DETECTION AND MONITORING OF HEART FAILURE IN REAL TIME

Project description

Easy, non-invasive and quick diagnosis of heart failure

Millions of Europeans suffer each year from heart failure (HF). It can be a chronic or acute condition that occurs when heart muscle can’t pump blood as it should. Narrowed arteries or high blood pressure are the main cause. Unfortunately, the standard diagnostics for HF is currently expensive, risky and complex. The EU-funded NIRT MONITOR project aims to change this situation by promoting prevention. It offers an innovative medical device that non-invasively measures left ventricular end diastolic pressure (LVEDP). Thanks to this device, diagnosis of HF will become easy and safe, reducing the number of hospitalisations by 80 %. The NIRT MONITOR device will be promoted for medical centres, internal medicine units, hospitals etc.

Objective

Heart Failure (HF) affects 15 million of Europeans and €6.41 billion are annually spent on its management and treatment by the healthcare system, CORALERT aims to favour the HF prevention and decrease its costs through its innovative NIRT MONITOR medical device. Gold standard procedures for diagnosing HF using catheterization are risky and complexes. As validated by clinical assay, NIRT MONITOR offers an alternative, safe and easy to use method to early diagnosis HF in real time by non-invasive measuring of LVEDP (Left Ventricular End Diastolic Pressure) providing physicians and in- and out-patient settings an early diagnosis of HF and its complications. NIRT MONITOR will improve the quality of life of patients while reducing hospitalizations by 30% and re-admissions by 80%. Cardiology, ICU, ER and Internal Medicine Units from hospitals (€5.1 billion of European market), GP offices and homecare settings will be the target users. NIRT MONITOR business model will be based on devices sales/leasing for early adopters and later from indirect sales/leasing through medical technology distributors. Revenues will be also generated by direct and indirect sales of disposables and by Cloud App payment fees. NIRT MONITOR will be an inexpensive solution (€10,000/device) in comparison with one catheter lab procedure (first two uses will save the 100% of the costs of one use of the standard method). NIRT MONITOR´s safety, easy to use, cost-efficient and accuracy will ensure its penetration into targeted European countries (Spain, France and Germany) and expansion over other European countries and US. We estimate a profit of ≈€38.5M after four years of commercialization with a ROI of 11.8 and a market share of 4.5%. We have filled US and PCT patent applications. To ensure the sucessful release of NIRT MONITOR into the market, a feasibility study will be performed during SME Phase 1 to evaluate any technical, commercial and financial issues related to the project.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-1

æ

Coordinator

CORALERT LTD
Net EU contribution
€ 50 000,00
Address
Tchelet 17
2017400 Misgav
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Other funding
€ 21 429,00